KCM
INSM icon

KRS Capital Management’s Insmed INSM Stock Holding History

KRS Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,244
Closed -$203K – 127
2026
Q1 		$203K Buy
+1,244
New +$191K 0.12% 112

Other funds holding INSM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

KRS Capital Management's INSM Position: Q2 2026 in Review

KRS Capital Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,244 shares — an estimated $203K sold.

KRS Capital Management first reported a position in INSM in Q1 2026 and held it in 1 quarter. The position peaked at $203K in Q1 2026. 180 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • KRS Capital Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • KRS Capital Management sold 1,244 Insmed shares in Q2 2026, an estimated $203K.
  • KRS Capital Management first reported a position in Insmed in Q1 2026 and held it in 1 quarter.
  • KRS Capital Management's Insmed position peaked at $203K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.